BEAM
Beam Therapeutics Inc.
Latest News for BEAM
JonesTrading analyst Soumit Roy maintained a Buy rating on Beam Therapeutics today and set a price target of $35.00. According to TipRanks, Roy is ......
Wedbush analyst David Nierengarten maintained a Buy rating on Beam Therapeutics on March 26 and set a price target of $65.00. The company’s shares ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beam Therapeutics (BEAM), KalVista Pharmaceuticals (......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ionis Pharmaceuticals (IONS) and Beam Therapeutics (......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stoke Therapeutics (STOK), Embecta Corporation (EMBC......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beam Therapeutics (BEAM – Research Report), Pelthos ......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BEAM | $27.41 | +4.1% | 1.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |